Intestinal bacteria contribute to the pathogenesis of non-alcoholic fatty liver disease
(NAFLD). Recently developed microbial profiling techniques are beginning to shed light on …

Liver cirrhosis (LC) is a chronic illness caused by inflammatory responses and progressive
fibrosis. Globally, the most common causes of chronic liver disease include persistent …

Mulberry leaves are one of the most commonly used medicinal and herbaceous traditional
Chinese medicines that are currently considered for the treatment of diabetes mellitus and …

NASH consists in lipid accumulation in hepatocytes that trigger oxidative stress, secretion of
proinflammatory cytokines leading to steatohepatitis (NASH). The study aimed to investigate …

Scope Nonalcoholic fatty liver diseases (NAFLD) range histopathologically from hepatic
steatosis to steatohepatitis. Chicoric acid has beneficial effects on obesity and liver injury …

Background: Several studies have explored the associations between interleukin-6 (IL-6)
gene polymorphisms and the susceptibility to liver diseases, however, results remain …

Inflammatory cytokines have been implicated as crucial contributors to the onset and
progression of non-alcoholic fatty liver disease (NAFLD). The exact mechanisms by which …

The alterations and low levels of circulating branched chain amino acids (BCAA s), leucine,
isoleucine, and valine, are associated with liver diseases. The study was designed to …

Non-alcoholic fatty liver disease (NAFLD) is a hepatic presentation of obesity and metabolic
syndrome. MicroRNA 26a (Mir-26a) has been reported to play functions in cellular …

Non-alcoholic fatty liver disease (NAFLD) is the most common form of liver disease, thus
becoming an epidemic in the Western world with a major impact on public health. NAFLD …